TruGenomix

TruGenomix Summary Financials People Technology Signals & News About TruGenomix is a provider of genomic blood test services intended to develop and diagnose for post-traumatic stress disorder. Rockville, Maryland, United States 11-50 Debt Financing Private www.trugenomix.com/ 19,027 Highlights Total Funding Amount $2.2M Number of Current Team Members 3 Number of Investors 3 Recent News & Activity Funding Round • Mar 24, 2021 TruGenomix raised $100,000 / Debt Financing Discover more funding rounds Funding Round • Nov 13, 2020 TruGenomix raised $75,000 / Debt Financing Discover more funding rounds Funding Round • Feb 14, 2020 TruGenomix raised $2,000,000 / Seed from Sanford Health and 2 other investors Discover more funding rounds VIEW ALL Details Industries Biotechnology Health Care Health Diagnostics Diversity Spotlight (US Only) Black / African American Founded Black / African American Led Headquarters Regions Washington DC Metro Area, East Coast, Southern US Founded Date Dec 17, 2017 Founders Charles Cathlin, Tshaka Cunningham, Yusuf Henriques Operating Status Active Last Funding Type Debt Financing Legal Name TruGenomix Health, Inc. Company Type For Profit Contact Email info@trugenomix.com TruGenomix is a precision behavioral health company with a mission is to save lives, reduce suffering and eradicate stigma from PTSD through earlier and more effective diagnosis and treatment. Our TruGenomix Platform is an evidence-based behavioral health platform that aggregates data from our patented TruGen-1genomic test, patient data, and otherexternal datasets to continuously expand behavioral health insights using machine learning and artificial intelligence. TruGen-1, utilizes Next-Generation Sequencing (NGS) technology combined with a highly specialized and curated panel of genes that are associated with behavioral and mental health conditions.